Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
98,488
+1,554
+2% +$40.6K 0.17% 69
2026
Q1
$2.72M Buy
96,934
+1,620
+2% +$43.1K 0.21% 56
2025
Q4
$2.37M Buy
95,314
+1,631
+2% +$41.1K 0.21% 63
2025
Q3
$2.39M Buy
93,683
+1,568
+2% +$38.7K 0.22% 60
2025
Q2
$2.23M Buy
92,115
+1,717
+2% +$40K 0.25% 59
2025
Q1
$2.29M Buy
90,398
+1,420
+2% +$37.2K 0.29% 59
2024
Q4
$2.36M Buy
88,978
+1,266
+1% +$34.3K 0.28% 57
2024
Q3
$2.54M Buy
87,712
+1,298
+2% +$37.9K 0.31% 55
2024
Q2
$2.42M Buy
86,414
+1,380
+2% +$38K 0.3% 55
2024
Q1
$2.36M Buy
85,034
+1,730
+2% +$48K 0.23% 58
2023
Q4
$2.4M Buy
83,304
+1,017
+1% +$30.7K 0.25% 50
2023
Q3
$2.73M Buy
82,287
+909
+1% +$32.1K 0.32% 42
2023
Q2
$2.98M Buy
81,378
+788
+1% +$30.7K 0.33% 36
2023
Q1
$3.29M Buy
80,590
+782
+1% +$33.8K 0.37% 28
2022
Q4
$4.09M Buy
79,808
+757
+1% +$36.3K 0.53% 21
2022
Q3
$3.46M Buy
79,051
+589
+0.8% +$28.6K 0.64% 21
2022
Q2
$4.11M Buy
78,462
+603
+0.8% +$30.7K 1.06% 10
2022
Q1
$4.03M Buy
77,859
+510
+0.7% +$26.5K 0.97% 13
2021
Q4
$4.57M Buy
77,349
+873
+1% +$43.3K 1.1% 9
2021
Q3
$3.29M Sell
76,476
-18,803
-20% -$833K 0.82% 20
2021
Q2
$3.73M Buy
+95,279
New +$3.71M 0.7% 28

Other funds holding PFE

Unison Advisors's PFE Position: Q2 2026 in Review

Unison Advisors increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $40.6K and bringing the position to 98,488 shares worth $2.37M. The position accounts for 0.17% of the portfolio, ranked #69.

Unison Advisors first reported a position in PFE in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.57M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Unison Advisors held 98,488 shares of Pfizer worth $2.37M as of Q2 2026.
  • Unison Advisors bought 1,554 Pfizer shares in Q2 2026, an estimated $40.6K.
  • Pfizer made up 0.17% of Unison Advisors's portfolio in Q2 2026, its #69 holding.
  • Unison Advisors first reported a position in Pfizer in Q2 2021 and has held it in 21 quarters since.
  • Unison Advisors's Pfizer position peaked at $4.57M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Unison Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.